Key Takeaways Itron shares are down 26% in three months and 31.6% in six months, lagging the industry, sector and S&P 500.Itron cut 2025 revenue guidance as bookings weaken and macro uncertainty clouds near-term demand.Itron's Grid Edge Intelligence momentum and new products offer long-term support despite headwinds.Itron, Inc. (ITRI) shares have plunged 26% in the past three months, underperforming the Zacks Electronics - Testing Equipment industry’s growth of 4.7%. Also, it has underperformed the Zacks Co ...

Core Insights - V2X, Inc. has been awarded a $72 million contract to provide support and engineering services for the Gateway Mission Router (GMR) [1] - The GMR is designed to enhance air-to-ground operations and adapt to evolving mission needs through open-standard interfaces, enabling a unified common operating picture [2] - The system supports the Department of Defense's Combined Joint All Domain Command and Control initiative, aiming for faster, data-driven decision-making across multiple domains [3] Company Developments - The contract represents a significant milestone for V2X as it continues to advance the GMR program and expand its applications within the U.S. military [4] - This new contract builds upon a previous $49 million contract, indicating ongoing investment and growth potential in the GMR program [4] - The estimated completion date for the current contract is June 25, 2030, highlighting a long-term commitment to the project [4] Company Overview - V2X specializes in integrating physical and digital environments to enhance mission readiness, optimize resource management, and improve security [5] - The company employs approximately 16,000 professionals and focuses on innovation across national security, defense, civilian, and international markets [5] - V2X incorporates AI and machine learning capabilities to address complex challenges across various operational domains [5]

NEWTOWN, Pa., Dec. 8, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm based in suburban Philadelphia, is investigating potential violations of the federal securities laws involving CoreWeave, Inc. (NASDAQ: CRWV), resulting from allegations of providing potentially misleading business information to the investing public. If you have information that could assist in the CoreWeave Investigation or if you are a CoreWeave investor who suffered a loss and would like to learn more, you ...

Core Viewpoint - Tempus AI, Inc. reported strong third-quarter FY25 earnings, leading to a reiterated Buy rating from BTIG analyst Mark Massaro with a price target of $96, despite current selling pressure on the stock [1]. Earnings Details - Tempus AI reported revenue of $334.21 million, exceeding analyst estimates of $328.73 million, representing an 84.7% year-over-year increase [2]. - The adjusted loss per share was 11 cents, better than the estimated loss of 17 cents [2]. - For FY25, the company raised its revenue guidance to $1.265 billion from a previous estimate of $1.260 billion [2]. Analyst View - The analyst anticipates that Tempus will secure additional pharmaceutical contracts for its data and services business [3]. - There is an expectation for average selling prices (ASPs) to increase due to a shift towards higher-priced tests, such as the xT CDx priced at $4,500 per test (up from $2,900 for xT LDT) and the xF liquid biopsy assay at $3,288 per test (up from $2,919) [3]. - Expansion of commercial payor coverage for xF and xT CDx is expected, along with continued development of Tempus's algorithm business [3]. Market Positioning - Tempus is positioned at the intersection of key trends including precision medicine, oncology (including liquid biopsies), AI and machine learning, and the shift towards personalized drug development and companion diagnostics for pharmaceutical companies [4]. - As of the publication date, Tempus shares were down 2.74% at $82.18 [4].

Financial Data and Key Metrics Changes - Q3 net sales reached $110.3 million, representing a year-over-year increase of 10.4%, exceeding the top end of guidance by approximately 40 basis points [17] - Adjusted EBITDA for Q3 was $3.6 million, with an adjusted EBITDA margin of 3.2%, marking the 17th consecutive quarter of positive adjusted EBITDA [18] - Gross margin for Q3 was 57.6%, within the medium-term target range, but a decline of 320 basis points compared to Q3 last year [18] - Average order value (AOV) was $2,209, reflecting a decline of 5.5% year-over-year but an increase of 6.5% quarter-over-quarter [17] Business Line Data and Key Metrics Changes - Engagement ring bookings returned to growth, marking an inflection point after a multi-year market normalization [9] - Wedding and anniversary band bookings achieved the largest quarter ever, with double-digit year-over-year growth [10] - Fine jewelry bookings grew 45% year-over-year, driven by both unit and average selling price (ASP) growth [11] Market Data and Key Metrics Changes - Total orders grew 17% year-over-year, while repeat orders increased by 16% year-over-year, indicating strong brand resonance [9] - The company noted stabilization in engagement ring average selling prices, with sequential ASP growth in the last two quarters [9] Company Strategy and Development Direction - The company aims to continue capturing market share in the $350 billion jewelry industry, leveraging its asset-light, data-driven business model [5] - Strategic brand investments and celebrity placements have significantly increased brand awareness, generating over 13 billion impressions in Q3 [12] - The company is focused on expanding its showroom footprint and enhancing its omnichannel shopping experience [40] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating industry-wide headwinds such as rising metal prices and tariffs, citing a globally diversified supply chain as a competitive advantage [24] - The company raised its full-year net sales guidance to 3-4.5% growth year-over-year, driven by improvements in engagement ring bookings and strong fine jewelry performance [22] - Management anticipates some impact from gold and platinum prices in Q4, which are near all-time highs, and the additional 25% tariff on India [24] Other Important Information - The company ended Q3 with approximately $73 million in cash and has generated approximately $12 million of free cash flow on a trailing 12-month basis [21] - The company has no debt on its balance sheet and has spent approximately $1.1 million on stock repurchases to date [22] Q&A Session Summary Question: Sustainability of engagement ring bookings growth and expectations for bridal recovery versus fine jewelry mix - Management is optimistic about the sustainability of engagement ring bookings growth and expects to continue outperforming the industry [26] Question: Adjusted EBITDA margin guidance and impact of metals pricing and tariffs - Management indicated that they have taken selective pricing increases and are continuously optimizing pricing to mitigate cost increases [28] Question: Top-line guidance for the full year and headwinds - Management noted that the top-line guidance factors in strong performance in engagement and fine jewelry, with caution due to the holiday season's variability [33] Question: Marketing efficiencies driving sales and leverage - Management highlighted improvements in marketing efficiency through better allocation of spend and machine learning models to enhance site conversion [37] Question: Capital priorities and factors driving upside in fine versus engagement jewelry - Management emphasized a strong balance sheet and flexibility to invest in showroom expansion and brand awareness while maintaining a focus on ROI [40]

Financial Data and Key Metrics Changes - Total revenue grew 25% to $755 million, driven by 15% organic growth and nearly 10% from M&A [3][27][28] - Adjusted EBITDA increased 23.8% to $236 million, with an adjusted EBITDA margin of 31.2%, slightly down from 31.5% in the prior year [3][27][28] - Adjusted earnings per share rose 14.6% to $0.47 [3][28] Business Line Data and Key Metrics Changes - The casualty business showed strong growth across all specialties, with high renewal retention and new business generation [4][19] - Property business returned to growth, driven by new business and high renewal retention, despite ongoing pricing pressures [18][19] - Underwriting management specialty grew significantly, with contributions from recent acquisitions adding over 30% to top-line growth [23][27] Market Data and Key Metrics Changes - The company noted a steady flow of business into the E&S channel, which helped maintain organic growth despite property pricing headwinds [24][32] - The property market is expected to face continued deterioration in pricing, with anticipated rate reductions of 20% to 30% [39][32] Company Strategy and Development Direction - The company is focused on strategic investments in talent, technology, and innovative products to drive long-term growth [5][6][30] - A commitment to M&A remains a top priority, with a robust pipeline for future acquisitions [28][25] - The company is deferring its 2027 target for a 35% adjusted EBITDA margin to prioritize growth opportunities [14][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit organic growth for 2025, marking the 15th consecutive year of such growth [7][30] - The company is optimistic about sustaining similar growth levels into 2026, despite potential market challenges [8][30] - Management highlighted the importance of recruiting and retaining top talent as a key driver for future success [6][16] Other Important Information - The company launched Ryan Alternative Capital Re, a collateralized sidecar to enhance its underwriting capacity [23] - Recent leadership changes were announced, with new Co-Presidents appointed to drive operational excellence and client impact [8][9] Q&A Session Summary Question: Can you unpack the 15% organic growth? - Management indicated that the growth was driven by submission growth, new business, and high renewal retention across all specialties [33][35] Question: How sustainable is the organic revenue growth in underwriting management? - Management expects continued double-digit organic growth in underwriting management, fueled by capital markets activity and strategic investments [50] Question: Will the current market environment influence talent investment decisions? - Yes, the company adjusts its talent investment strategy based on market conditions, focusing on areas with growth potential [51] Question: What are the expectations for margin improvement in 2026? - Management anticipates continued margin pressures in 2026 due to ongoing investments in talent, but modest margin expansion is expected in the long term [45][59] Question: How does the company view the current dynamics in the London specialty marketplace? - The company is revisiting its strategy in London, focusing on improving offerings and addressing potential conflicts [60]

Company Overview - V2X, Inc. is a leading provider of global mission solutions, focusing on integrating physical and digital environments to enhance mission readiness and security [4]. Financial Results Announcement - V2X will report its third quarter 2025 financial results on November 3, 2025, after market close [1]. - A conference call will be held at 4:30 p.m. ET on the same day to discuss the results [1]. Conference Call Details - U.S.-based participants can join the conference call by dialing 877-300-8521, while international participants can call 412-317-6026 [2]. - A live webcast and accompanying slide presentation will be available on the V2X website [2]. Replay Information - A replay of the conference call will be accessible on the V2X website for one year following the call [3]. - Telephonic replay will be available until November 17, 2025, with specific numbers for domestic and international callers [3].

Core Insights - V2X, Inc. has appointed Jeff Cheatham as Vice President of Contracts and Subcontracts, responsible for overseeing contract strategy, negotiation, and administration across the enterprise [1][2] - Cheatham has over 25 years of experience in federal contracting and procurement, previously serving as Vice President of Contracts at Peraton, where he led large-scale contracts organizations and negotiated multi-billion-dollar agreements [2][3] - Jeremy Nance, General Counsel at V2X, highlighted Cheatham's ability to drive operational excellence and collaboration, aligning with V2X's mission to deliver innovative solutions globally [3] Company Overview - V2X specializes in building innovative solutions that integrate physical and digital environments, enhancing readiness, optimizing resource management, and boosting security across various markets [4] - The company employs approximately 16,000 professionals and focuses on national security, defense, civilian, and international markets, utilizing AI and machine learning to address operational challenges [4]

Core Insights - Asda has appointed Charlotte Rhodes as vice-president of its own-brand division, effective from early December 2025, bringing over 20 years of retail experience [1] - Rhodes previously held senior roles at Coles in Australia, where she led the Own Brand Transformation agenda, improving operational capabilities [2][3] - Asda aims to strengthen its own-brand ranges to meet customer expectations for quality and value, leveraging Rhodes' expertise in brand development [4] Company Strategy - The appointment of Rhodes is part of Asda's strategy to enhance its own-brand offerings, ensuring they remain competitive in the market [1][4] - Asda has partnered with Microsoft to transition to a cloud-first operational model, utilizing AI and machine learning technologies to support this shift [4] Technology Initiatives - In early 2025, Asda began a trial of live facial recognition technology in five stores in Greater Manchester to improve safety amid rising retail crime [5]

Financial Data and Key Metrics Changes - The company reported Q1 revenue of $14 million, rebounding from $12.4 million in Q4 of fiscal 2025, indicating a return to growth after a challenging previous quarter [3][7] - Year-over-year revenue comparison appears flat, but the company views this quarter as a stabilization point and the start of renewed momentum [8] - The operating loss for Q1 was $0.5 million compared to an income of $1.3 million in the same quarter last year, with adjusted EBITDA slightly positive at $60,000 [8][10] Business Line Data and Key Metrics Changes - The research services business contributed $13.7 million to the total revenue, while the data business provided the remaining amount [7] - Gross margin decreased to 43% from 50% in Q1 of the previous year, primarily due to increased outsourced lab service costs [8][9] - Operating expenses rose to $6 million, with intentional increases in R&D and sales and marketing to support the data business [9] Market Data and Key Metrics Changes - Customer cancellations have decreased, and bookings to revenue conversion has improved, indicating stronger customer relationships [4] - The macro environment remains challenging, with biotech funding and R&D budgets under pressure, but there are signs of improvement [3][20] Company Strategy and Development Direction - The company is focused on driving value opportunities in Corellia and its data business while expanding its core TOS platform [3][4] - The radiopharmaceutical services platform is being enhanced with new infrastructure and capabilities, aiming to reduce costs and improve gross margins [4] - The company sees significant long-term opportunities in AI and machine learning for drug discovery [5] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about improving market conditions, although they do not expect a rapid recovery [20] - The company anticipates sequential revenue growth and margin expansion as they bring more work in-house [11] - There is confidence in the ability to execute and deliver shareholder value, supported by a strong balance sheet and no debt [11] Other Important Information - The company ended Q1 with $10.3 million in cash, up $0.5 million from year-end, and expects to remain cash neutral in Q2 [10][11] - Management is committed to investing in organic growth and capital expenditures tied to expansion [10] Q&A Session Summary Question: Any changes in the strategy on the data licensing business? - Management confirmed there are no changes in strategy, but they see potential and customer engagement in the data licensing business [14] Question: How would you characterize the size of the opportunity in the data business? - Management stated it is still early to predict the exact size and success of the opportunity, but there is potential and interest [15] Question: What frameworks are being considered for structuring deals with Corellia? - Management is looking for external partners and funding to support Corellia's advancement and is encouraged by the compelling data emerging from the platform [16] Question: Can you provide insights on the broader investment landscape? - Management noted it remains a tough environment but sees signs of improvement and feels well-positioned to capitalize on opportunities [20] Question: Will Q2 revenue increase compared to last year? - Management anticipates revenue will increase on a quarterly basis but did not provide specific guidance on numbers [27]